Professional Summary
Education & Certifications
- Fellowship: Stanford University Pain Management Fellowship (2014) CA
- Medical Education: University of Colorado School of Medicine (2008) CO
- Internship: University of Colorado General Surgery Residency (2009) CO
- MSc, Stanford University, Epidemiology and Clinical Research (2017)
- Board Certification: American Board of Anesthesiology, Pain Medicine (2014)
- Board Certification: American Board of Anesthesiology, Anesthesiology (2013)
- Residency: University Of Virginia Health System (2012) VA
Publications
-
Self-Loathing Aspects of Depression Reduce Postoperative Opioid Cessation Rate
Hah, J. M., Mackey, S., Barelka, P. L., Wang, C. K. M., Wang, B. M., Gillespie, M. J., … Carroll, I. R. (2014). Self-Loathing Aspects of Depression Reduce Postoperative Opioid Cessation Rate. PAIN MEDICINE, 15(6), 954–64. -
In reply.
Schmidt, P. C., Ruchelli, G., Mackey, S. C., & Carroll, I. R. (2014). In reply. Anesthesiology, 121(2), 424–26. -
Perioperative Gabapentinoids Choice of Agent, Dose, Timing, and Effects on Chronic Postsurgical Pain
Schmidt, P. C., Ruchelli, G., Mackey, S. C., & Carroll, I. R. (2013). Perioperative Gabapentinoids Choice of Agent, Dose, Timing, and Effects on Chronic Postsurgical Pain. ANESTHESIOLOGY, 119(5), 1215–21. -
Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
Hah, J., Mackey, S. C., Schmidt, P., McCue, R., Humphreys, K., Trafton, J., … Carroll, I. (2017). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA Surgery. -
Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial.
Hah, J. M., Cramer, E., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., … Carroll, I. (2019). Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open, 2(3), e190168. -
Sacroiliac Joint Radiofrequency Ablation with a Multi lesion Probe: A Case Series of 60 Patients
Schmidt, P. C., Pino, C. A., & Vorenkamp, K. E. (2014). Sacroiliac Joint Radiofrequency Ablation with a Multi lesion Probe: A Case Series of 60 Patients. ANESTHESIA AND ANALGESIA, 119(2), 460–62. -
Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy
Lipton, R. B., Schmidt, P., & Diener, H.-C. (2017). Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy. HEADACHE, 57(5), 756–65. -
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Spierings, E. L. H., Brandes, J. L., Kudrow, D. B., Weintraub, J., Schmidt, P. C., Kellerman, D. J., & Tepper, S. J. (2018). Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine. CEPHALALGIA, 38(2), 215–24. -
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
Dodick, D. W., Tepper, S. J., Friedman, D. I., Gelfand, A. A., Kellerman, D. J., & Schmidt, P. C. (2018). Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. HEADACHE, 58(7), 986–92. -
Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition
Schmidt, P., & Rao, S. (2018). Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition. PAIN MANAGEMENT, 8(4), 297–306. -
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
Tepper, S. J., Dodick, D. W., Schmidt, P. C., & Kellerman, D. J. (2019). Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches. Headache. -
Use of Most Bothersome Symptom as a Co-Primary Endpoint in an Acute Treatment of Migraine Trial
Dodick, D. W., Tepper, S. J., Friedaman, D., Gelfand, A., Cowan, R. P., Schmidt, P., … Kellerman, D. J. (2017). Use of Most Bothersome Symptom as a Co-Primary Endpoint in an Acute Treatment of Migraine Trial. CEPHALALGIA. SAGE PUBLICATIONS LTD. -
Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials.
Hindiyeh, N. A., Kellerman, D. J., & Schmidt, P. C. (2019). Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials. Headache. -
Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery Secondary Analysis of a Randomized Clinical Trial
Hah, J. M., Cramer, E., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., … Carroll, I. (2019). Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery Secondary Analysis of a Randomized Clinical Trial. JAMA NETWORK OPEN, 2(3). -
Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials
Hindiyeh, N. A., Kellerman, D. J., & Schmidt, P. C. (2019). Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials. HEADACHE, 59(5), 819–24. -
Efficacy of Qtrypta (zolmitriptan intracutaneous system) Before and After the Initiation of CGRP Antibody Therapy in Subjects with Migraine - a Preliminary Assessment
Hindiyeh, N., Schmidt, P., Engels, J., Halladay, W., & Kellerman, D. (2019). Efficacy of Qtrypta (zolmitriptan intracutaneous system) Before and After the Initiation of CGRP Antibody Therapy in Subjects with Migraine - a Preliminary Assessment. CEPHALALGIA, 39(1_SUPPL), 394. -
Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial.
Hah, J. M., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., Clay, D., … Carroll, I. (2020). Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial. Journal of Pain Research, 13, 2959–70. -
Erector Spinae Regional Anesthesia for Robotic Coronary Artery Bypass Surgery Is Not Associated With Reduced Postoperative Opioid Use: A Retrospective Observational Study.
Moll, V., Ward, C. T., Jabaley, C. S., O'Reilly-Shah, V. N., Boorman, D. W., McKenzie-Brown, A. M., … Schmidt, P. C. (2020). Erector Spinae Regional Anesthesia for Robotic Coronary Artery Bypass Surgery Is Not Associated With Reduced Postoperative Opioid Use: A Retrospective Observational Study. Journal of Cardiothoracic and Vascular Anesthesia. -
Building regional anesthesia capacity in limited-resource settings: a pilot study evaluating a 4-week curriculum
Moll, V., Schmidt, P. C., Amos, C., Workneh, R. S., Tadesse, M., Mulugeta, E., & Abate, A. (2021). Building regional anesthesia capacity in limited-resource settings: a pilot study evaluating a 4-week curriculum. PAIN MANAGEMENT, 11(1), 29–37. -
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
Nahas, S. J., Hindiyeh, N., Friedman, D. I., Elbuluk, N., Kellerman, D. J., Foreman, P. K., & Schmidt, P. (2021). Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine. The Journal of Headache and Pain, 22(1), 37. -
Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018)
Hah, J., Mackey, S. C., & Schmidt, P. (2022). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018). JAMA SURGERY. -
Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018)
Hah, J., Mackey, S. C., & Schmidt, P. (2022). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018). JAMA SURGERY, 157(6), 553.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds »
- A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine »
- Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl »
- Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica »
- A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers »
- Stanford Accelerated Recovery Trial (START) »
Practice Locations
Pain Management Center in San Jose San Jose, CA
San Jose, CAPain Management Center in San Jose
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(22 reviews)
View More »